ATE495760T1 - Gefriergetrocknete zusammensetzung aus einer inaktivierten virushülle mit membranfusionsaktivität - Google Patents

Gefriergetrocknete zusammensetzung aus einer inaktivierten virushülle mit membranfusionsaktivität

Info

Publication number: ATE495760T1
Authority: AT; Austria
Prior art keywords: freeze; dried composition; inactivated virus; membrane fusion; fusion activity
Prior art date: 2004-06-14

Application number

AT05749035T

Other languages

English (en)

Inventor

Takafumi Ueda

Original Assignee

Ishihara Sangyo Kaisha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-14

Filing date

2005-06-10

Publication date

2011-02-15

2005-06-10 Application filed by Ishihara Sangyo Kaisha filed Critical Ishihara Sangyo Kaisha

2011-02-15 Application granted granted Critical

2011-02-15 Publication of ATE495760T1 publication Critical patent/ATE495760T1/de

Links

230000034217 membrane fusion Effects 0.000 title abstract 3
241000700605 Viruses Species 0.000 title abstract 2
108010003533 Viral Envelope Proteins Proteins 0.000 abstract 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1
239000003531 protein hydrolysate Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT05749035T 2004-06-14 2005-06-10 Gefriergetrocknete zusammensetzung aus einer inaktivierten virushülle mit membranfusionsaktivität ATE495760T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2004176105		2004-06-14
PCT/JP2005/010720 WO2005120579A1 (ja)	2004-06-14	2005-06-10	膜融合活性のある不活性化ウイルスエンベロープの凍結乾燥組成物

Publications (1)

Publication Number	Publication Date
ATE495760T1 true ATE495760T1 (de)	2011-02-15

Family

ID=35502838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05749035T ATE495760T1 (de)	2004-06-14	2005-06-10	Gefriergetrocknete zusammensetzung aus einer inaktivierten virushülle mit membranfusionsaktivität

Country Status (7)

Country	Link
US (2)	US20080102524A1 (de)
EP (1)	EP1757312B1 (de)
AT (1)	ATE495760T1 (de)
DE (1)	DE602005026005D1 (de)
DK (1)	DK1757312T3 (de)
ES (1)	ES2357772T3 (de)
WO (1)	WO2005120579A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2236520A1 (de) *	2009-03-31	2010-10-06	Leukocare Ag	Stabilisierungszusammensetzung für immobilisierte Biomoleküle
CN109432017B (zh) *	2018-11-19	2021-04-23	哈药集团生物疫苗有限公司	鸡痘耐热冻干保护剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5795917A (en) *	1980-12-04	1982-06-15	Takeda Chem Ind Ltd	Preparation of inactivated sendai virus vaccine
DD299213A7 (de) *	1988-05-04	1992-04-09	Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De	Verfahren zur stabilisierung eines lebendvirusimpfstoffes gegen temperatureinwirkung
US5631237A (en) *	1992-12-22	1997-05-20	Dzau; Victor J.	Method for producing in vivo delivery of therapeutic agents via liposomes
WO1996029096A1 (en) *	1995-03-17	1996-09-26	Hisamitsu Pharmaceutical Co., Inc.	Gene transfer preparation
FR2742756B1 (fr) *	1995-12-22	1998-04-03	Pasteur Merieux Serums Vacc	Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
DE69940354D1 (de) *	1998-11-16	2009-03-12	Introgen Therapeutics Inc	Adenovirus-formulierungen zur gentherapie
US6225289B1 (en) *	1998-12-10	2001-05-01	Genvec, Inc.	Methods and compositions for preserving adenoviral vectors
US7314614B1 (en) *	1999-11-02	2008-01-01	Dnavec Research, Inc.	Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
CN100532559C (zh) *	2000-02-02	2009-08-26	安增子摩祺株式会社	用于基因转移的病毒包膜载体
PL212047B1 (pl) *	2000-11-23	2012-08-31	Bavarian Nordic As	Zmodyfikowany wirus krowianki szczepu Ankara MVA-BN i jego pochodna, genom i zawierające je kompozycja farmaceutyczna, zwłaszcza szczepionka oraz ich zastosowania
JPWO2003014338A1 (ja) *	2001-08-02	2004-11-25	アンジェスＭｇ株式会社	不活性化ウイルスエンベロープの製造方法
KR100477103B1 (ko) *	2001-12-19	2005-03-18	삼성에스디아이 주식회사	금속유도화 측면결정화방법을 이용한 멀티플 게이트 박막트랜지스터 및 그의 제조방법
CA2497313A1 (en) *	2002-08-27	2004-04-29	Anges Mg, Inc.	Biomolecule transfer method using virus envelope and composition and system therefor

2005
- 2005-06-10 AT AT05749035T patent/ATE495760T1/de active
- 2005-06-10 EP EP05749035A patent/EP1757312B1/de not_active Expired - Lifetime
- 2005-06-10 ES ES05749035T patent/ES2357772T3/es not_active Expired - Lifetime
- 2005-06-10 US US11/629,289 patent/US20080102524A1/en not_active Abandoned
- 2005-06-10 DE DE602005026005T patent/DE602005026005D1/de not_active Expired - Lifetime
- 2005-06-10 WO PCT/JP2005/010720 patent/WO2005120579A1/ja not_active Ceased
- 2005-06-10 DK DK05749035.1T patent/DK1757312T3/da active
2009
- 2009-10-20 US US12/582,115 patent/US8043610B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20100040580A1 (en)	2010-02-18
DE602005026005D1 (de)	2011-03-03
ES2357772T3 (es)	2011-04-29
EP1757312B1 (de)	2011-01-19
DK1757312T3 (da)	2011-04-11
US20080102524A1 (en)	2008-05-01
EP1757312A1 (de)	2007-02-28
US8043610B2 (en)	2011-10-25
EP1757312A4 (de)	2008-01-16
WO2005120579A1 (ja)	2005-12-22

Similar Documents

Publication	Publication Date	Title
CL2008003794A1 (es)	2009-03-20	Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
AR039013A1 (es)	2005-02-02	Optimizacion de procedimiento de glicano en plantas
DK1422237T3 (da)	2007-06-11	Fremgangsmåder til rekombinant frembringelse af antifusogene peptider
PE20091218A1 (es)	2009-08-14	Anticuerpo anti-glipicano 3 con cinetica en plasma mejorada
NO980881L (no)	1998-04-27	Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrer
AR029759A1 (es)	2003-07-16	Variante de glucoamilasa original, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de fermentacion y metodo para mejorar la estabilidad termica.
DK1939281T4 (da)	2014-08-25	Immortaliserede andecellelinjer til virusproduktion
CY1114598T1 (el)	2016-10-05	Μεθοδος για την ενισχυση ενος ιου φυσαλιδωδους νοσου υπο συνθηκες ελευθερες ορου
PE20110310A1 (es)	2011-05-29	Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
AR036322A1 (es)	2004-09-01	Metodos y composiciones para sacarificacion y fermentacion simultaneas
AR080331A2 (es)	2012-03-28	Proteina nef-tat-his o nef-mutada tat-his, metodo para prepararla y metodo para producir una vacuna que comprende dicha proteina
EA200801756A1 (ru)	2009-02-27	Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
NO20082133L (no)	2008-06-16	Immunoglobulin-fusjonsproteinformuleringer
WO2005056808A3 (en)	2006-11-09	Immobilization of biocatalysts by template-directed silicate precipitation
NO20065084L (no)	2006-12-01	Interferon-alfa polypeptider og konjugater
MXPA03005548A (es)	2004-04-20	Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
MX2009010492A (es)	2009-10-19	Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped.
ATE430195T1 (de)	2009-05-15	Verfahren und zusammensetzungen zur reinigung von nukleinsäure aus einer wirtszelle
NO20052363L (no)	2005-08-08	Interferon-alfa polypeptider og konjugater
NO20062709L (no)	2006-08-11	Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
EP2351843A3 (de)	2011-11-09	Vektoren-systeme aus tollwut-viren und deren zusammensetzungen und methoden
CO6290699A2 (es)	2011-06-20	Termoestabilizacion de proteinas
TR200400639T4 (tr)	2004-05-21	Donmaya-karşı proteinler, bunların üretimleri ve kullanımları
MXPA04012601A (es)	2005-09-30	Medio de cultivo de celulas madre-progenitoras autologas humanas y sus aplicaciones.
AR054599A1 (es)	2007-06-27	Proteccion de la proteina krp mutante negativa dominante contra una inhibicion activa del complejo cdk -ciclina por la krp de tipo salvaje

Legal Events

Date

Code

Title

Description

2011-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1757312

Country of ref document: EP